ABSTRACT. Myo-inositol transport and metabolism were studied in cultured human skin fibroblasts exposed to potentially toxic levels of glucose or galactose. Although variable among I I different cell lines, the myo-inositol level in confluent cells, ranging from 10-50 nmol/mg protein, was constant with passage. A high-affinity transport system for myo-inositol had an apparent Kt of 55 pM and V, of 16 pmol/min/mg protein. No obvious relationship existed between cellular levels and transport capacity. Dependency on sodium was complex. When medium sodium was lowered to 23 mM, myo-inositol uptake ceased after about 1 h. However, the initial rate of myo-inositol uptake only showed a sodium dependence at low myo-inositol concentrations. Both phloretin and phloridzin inhibited myo-inositol uptake. Phloridzin had a Ki of 60 pM. and phloretin was either a noncompetitive or uncompetitive inhibitor. Glucose and galactose were only weak competitive inhibitors, with a K1 of 30 mM and 65 mM, respectively. After 24 h of incubation with myo-[2-3Hjinositol, only 10% of the total cell label was incorporated into phospholipid. Compared with control media with 5 mM glucose, the incubation of confluent cells in media with 20 mM glucose had little effect on intracellular glucose and sorbitol, whereas cells incubated in control media supplemented with 5 mM galactose showed a large increase in galactose and polyol levels. In media with more than 200 WM of myo-inositol, neither treatment had an effect on myo-inositol levels after 24 h. The uptake and incorporation of 11 pM myo-[2-3Hjinositol and incorporation into phospholipid were studied after cells had been previously exposed for 24 to 48 h to media supplemented with 15 mM glucose or galactose. Compared with controls, fibroblasts with a 24-h exposure to 20 m M glucose showed a 10% decrease in myo-inositol uptake. When the exposure was extended to 48 h, preconditioning with galactose as well as glucose elicited the same 10% reduction in uptake. Phosphoinositide labeling in fibroblasts exposed to 20 mM glucose was reduced in parallel. These cells offer a unique opportunity for the study of sugar toxicity in human tissue: they can be exposed to high levels of glucose without significant glucose or polyol accumulation~or can be made to accumulate polyol by exposure to moderate levels of galactose. The expression of a hexose-induced reduction in myo-inositol transport required 24 to 48 h of exposure of the fibroblasts to elevated concentrations of glucose or galactose and may not be related to a competitive inhibitory
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Cultured cells have been used to model the metabolic milieu of diabetes mellitus and in particular to study the effect of hyperglycemia alone. In retinal capillary pericytes (7). cultured neuroblastoma cells (8) , retinal pigment epithelial cells (9, lo), cultured aortic endothelial cells (I I), and glomemlar mesangial cells ( 1 2), glucose in high concentrations may act as a competitive or noncompetitive inhibitor of mvo-inositol uptake, and extended exposure of the cells to elevated levels of glucose may lead to a reduction in cell mvo-inositol content (8, (10) (11) (12) (13) . Galactose is at best a very weak competitive inhibitor of mvoinositol uptake, but prolonged exposure to elevated levels of galactose has also been shown to produce "diabetic-like" abnormalities in myo-inositol metabolism in cultured cells (14) . A reduction in tissue myo-inositol content has been detected in The reduction in cellular myo-inositol levels that accompanies incubations with high levels of glucose or galactose may be at least partially prevented by concomitant treatment with an inhibitor of aldose reductase (7, 10, 12, 14) , suggesting that the synthesis and accumulation of polyol may be responsible, at least in part, for the alterations in myo-inositol metabolism.
However, the use of cultured cells to study the effects of glucose or galactose on rn~lo-inositol metabolism has yielded conflicting results ( I 3). Even in the experimental diabetic animal. paradoxical changes in myo-inositol levels have been detected in certain tissues on prolonged exposure to hyperglycemia (16) . One of the underlying assumptions of the polyol toxicity hypothesis in diabetes mellitus is that the "target cells" exposed to elevated extracellular glucose levels as a consequence of hyperglycemia must accumulate glucose intracellularly because of the presence of noninsulin-dependent facilitated glucose diffusion and a ratelimiting glucokinase activity. As a consequence, cells that are relatively enriched in one or more aldehyde oxidoreductases, such as aldose reductase, will accumulate sorbitol resulting from activation of the polyol pathway. We reasoned that fibroblasts would be uniquely suited for examination of the polyol hypothesis because their capacity to transport glucose is thought to be weak and increased polyol pathway activity is dependent on intracellular glucose levels. Evidence shows that human fibroblasts express an energy and sodium-dependent high-affinity transporter for mjto-inositol that may be regulated by a gene on the long arm of chromosome 2 1 ( 17) . According to the hypothesis, myo-inositol deficiency would probably only develop in fibroblasts exposed to elevated glucose concentrations if extracellular glucose were to act as a strong competitive inhibitor of myo-inositol transport and that under these circumstances the use of mammalian fetal serum-like concentrations of extracellular myo-inositol would eliminate the expression of the deficiency state. Alternatively, because investigators have demonstrated that human skin fibroblasts readily take up galactose and convert it to galactitol ( 18) . exposure to elevated galactose concentrations might result in the development of a mj~(rinositol deficiency in the absence of a glucose effect because the mechanism might involve the polyol pathway selectively and not competitive inhibition. To answer these questions, we first delineated the nature of mjv-inositol transport in human skin fibroblasts and then examined the effects of elevated glucose or galactose concentrations on mjv-inositol metabolism.
MATERIALS A N D METHODS
Cell cttlture. Human fibroblasts were grown in our cell culture facility after procurement of biopsy samples from 1 I individuals with no identifiable genetic diseases. The biopsies were performed at the time of an elective herniorrhaphy in seven males and two females who were 2 mo to 13 y of age. One 9-y-old female underwent excision of a cardiac tumor, and a 5-y-old male had idiopathic mental retardation and asthma. Fibroblasts were grown in 25-cm' flasks in MEM (JRH Biosciences, Lenexa. KS) supplemented with 2 mM glutamine and containing 20% FBS (Whittaker Bioproducts. Walkersville. MD). They were incubated at 37°C in 5% COz in air as described by States et ul. (19) . Cultures were passed weekly and used at confluence. They were refed 1 d before the experiments. Most lots of FBS contain about I mM mjv-inositol. In these experiments the mj30-inositol concentration in MEM supplemented with 20% FBS was 224 f 6 pM (n = 36).
Transport stltdies. Experiments on the uptake of m~30-[2-'H] inositol were performed in MEM without serum to which was added a sterile mixture of mjlo-[2-'H]inositol and I4C-polyethylene glycol 4000 with a tracer ratio of about 5: I. For concentration dependence experiments, varying amounts of a sterile 50 mM myo-inositol stock solution were added; the amount of label was increased at the higher concentrations of mjvbinositol to partially offset the reduction in specific activity. For experiments testing the effects of elevated sugar levels. aliquots of sterile solutions of 0.5 M glucose or galactose were added to the medium. For sodium dependence studies, the media were prepared by mixing normal MEM with MEM in which the NaCl had been replaced by choline chloride (GIBCO Laboratories. Grand Island, NY).
Flasks were removed from the incubator to initiate the incubation. The medium was gently aspirated. 4-5 mL of fresh medium containing isotopes and additions were added. and the flasks were returned to the incubator for the indicated times. Phloridzin or phloretin was added as 50 mM solutions in 50% ethanol. Ethanol alone up to 1 % had no effect on the uptake of ~)IJ-o-(2-'Hlinositol.
At the end of the incubation. the medium was removed. and cells were washed twice with PBS at room temperature. Cells were lysed by adding 2 mL of ice-cold water and placing the flasks on ice for at least 1 min. The contents were scraped and transferred to tubes along with a 2-mL water rinse. For gas-liquid chromatography studies an internal standard of 20 nmol each of ribitol and a-methylmannopyranoside were added. Samples of the suspension were taken for determination of protein. The remainder was centrifuged at 40 000 x for 15 min at 4°C. The supernatant was recovered. and either a portion was counted directly or the entire fraction was evaporated in a vacuum oven at 40" for liquid scintillation counting. For determination of incorporation of rn~~o-[?-'Hlinositol into lipid, the pellet was washed once by resuspending in 4 mL of cold water and recentrifuged.
Samples were counted in ACS-I1 containing 10% water or in BCS containing 5% water. Triplicate 10-pL samples of the labeled incubation media were counted to obtain a IJC/'H ratio for calculation of trapped extracellular space and to calculate the specific activity of the rn~?o-[2-'H]inositol using the known concentration of rn~9o-inositol in the medium.
Metaholitc. levels. Gas-liquid chromatography was used to quantitate m~vrinositol, the polyols, sorbitol or galactitol, and the carbohydrates. glucose and galactose. Samples were dried under N2 and trimethylsilyl derivatives formed by stimng overnight with 80 pL of mixture consisting of pyridine/ bis(trimethylsilyl)trinuoroacetamide/trimethylch1orosilane in a ratio of 1 : 1 :0.05. Chromatography was performed using a PerkinElmer model 3920 with flame ionization detector (Perkin-Elmer.
Norwalk, CT). Separations were accomplished using a 6-foot x 4-mm glass column packed with 3% SP-2100 on Supelcoport (Supelco, Bellafonte. PA).
Protein was measured by the method of Lowry cJ/ uI. (20) . Except as noted, chemicals were from Sigma Chemical Co. (St. Louis, MO). M~~tr[2-~H]lnositol. 14C-polyethylene glycol 4000. and liquid scintillation mixtures (ACS-11 and BCS) were obtained from Amersham Corp. (Arlington Heights. IL). Kinetic parameters were derived by nonlinear least-squares regression analyses of data using SigmaPlot version 4 (Jandel Scientific. Corte Madera. CA). The 1 test was used to compare uptake rates. phosphatidylinositol biosynthetic rates, and metabolite levels.
RESULTS
The time course for uptake of several concentrations of m!vinositol is shown in Figure 1 . Uptake was found to be linear with time for the first 5 h (lnscrt) but began to slow by 24 h. We therefore used uptake at 30 to 120 min to further characterize mjv~inositol transport. The incorporation of mj,tr[2-'Hlinositol into fibroblast lipid was also examined in these experiments, and the data are presented in Figure I . The cells were lysed with water. the extract was centrifuged at 40 000 x g for 15 min, and the pellet washed and counted. the membrane pellets were extracted and lipids separated by thin-layer chromatography. Essentially all of the label was found in phosphatidylinositol. If the incubation was stopped with cold trichloroacetic acid rather than water, label could also be found in polyphosphoinositides. but this amount was only a few percent of the label in phosphatidylinositol.
The concentration dependence of mycrinositol transport was determined in experiments using 1 1 to 400 pM mjttrinositol and incubation times of 30 min to 2 h. This concentration range was chosen because the focus of this study was on the effects of sugar toxicity on the physiologically relevant high-affinity transport system. Fitting the data to a Michaelis-Menten equation revealed a V,, of 15.8 + 0.9 pmol/min/mg protein and an apparent K, of 55 + 9 r M .
The effect of medium sodium concentration on uptake of I I r M and 110 HM tnjv-inositol with time is shown in Figures 3A  and 3B , respectively. Reduction of sodium concentration from 134 to 67 mM had little effect on uptake at either mj9u-inositol concentration for up to 120 min. However. with only 23 mM sodium in the bathing medium the transport of mjv-inositol was significantly reduced at longer times. The permeability characteristics ofthe fibroblasts may have been perturbed at the extreme medium sodium concentration of 23 mM. The uptake of tnj9tr [2-'Hlinositol at 30 min in the presence of varying concentrations of sodium is shown in Figure 4 . At tnjv-inositol concentrations near the K, for transport, sodium ion concentrations had little effect. At higher concentrations of tnjv+inositol, the initial rate of uptake was actually higher as the sodium concentration was decreased, whereas at 1 1 pM mj.t+inositol uptake appeared to have a dependence on sodium.
The inhibition of m?vrinositol uptake by phloridzin and phloretin is shown in Figure 5 as the Lineweaver-Burk transformations of the kinetic data. Phloridzin acted as a competitive inhibitor of mjv-inositol uptake with a K, of approximately 60 pM. Phloretin, the aglycan form of phloridzin. proved to be an uncompetitive or noncompetitive inhibitor of tnjv-inositol uptake. The inhibition of mj9trinositol uptake by glucose and galactose was determined in experiments using I I to 200 pM mjltrinositol with 5-20 mM glucose or 5 mM glucose and 5-15 mM galactose. Both glucose and galactose were only weak competitive inhibitors of uptake. With Lineweaver-Burk transfor-BERRY ET .4L mations of the kinetic data, the K, of glucose and galactose was determined to be 30 mM and 65 mM, respectively. Fibroblasts were incubated for 0 to 48 h with 20 mM glucose or 15 mM galactose. The uptake of myo-[2-'H]inositol and its incorporation into lipid were measured for 2 to 4 h after changing the medium to MEM without serum. Results of the uptake determinations, normalized to the control values obtained with normal MEM (5 mM glucose) on each day of the experiment, are presented in Table 1 . Neither sugar was a competitive inhibitor of myo-inositol uptake under the conditions studied. However, cells incubated in 20 mM glucose for 24 h showed about a 10% inhibition of myo-inositol uptake from the same medium. and by 48 h a similar inhibition was observed in the galactose treated cells as well. Label incorporated into lipid simulated the same pattern as label in the supernatant.
Levels of mpo-inositol were determined by gas-liquid chromatography in several lines of fibroblasts from donors 2 mo to 9 y of age. Results for a given line were consistent and remained constant for 6 to 14 passages. Several of the determinations were performed in more than 15 separate experiments. In addition, little variation occurred in myo-inositol levels in a particular line regardless of whether the fibroblast extracts were prepared immediately or several hours after removal of the media with 20% FBS. As seen in Figure 6 , although variability was observed from line to line, no obvious relationship with the age of the donor could be discerned. Ranging from 10-50 nmol/mg protein, the cell mvo-inositol content varied by as much as 5-fold. No obvious relationship existed between cellular levels and the capacity for transport of mvo-inositol.
We examined the effect of a 24-h incubation with elevated glucose or galactose on mvo-inositol levels. Neither sugar had an effect on fibroblast myo-inositol levels ( Table 2 ). Glucose at 20 mM had little effect on the fibroblast content of glucose and polyol. In contrast, galactose at only 5 mM raised the cell content of galactose and polyol (galactitol) many fold but had no effect on the fibroblast myo-inositol levels. Similar results were found after 48 and 72 h of incubation.
DISCUSSION
Human skin fibroblasts exhibited a high-affinity transport system for myo-inositol with an apparent K, of 55 pM, which is near the normal serum concentration for m.vo-inositol in anyone other than a fetus or newborn infant. The rate of transport was (21) (22) (23) (24) (25) (26) and in cells in culture (8-12, 18, 27-29) . Studying fibroblasts during active cell division or in the nonconfluent state, Fruen and Lester (17) described a high-affinity sodium-dependent myo-inositol transport system with an apparent K, of 35.4 pM and V,,, of 5.8 pmol/min/mg protein. Both phloretin and its glycosylated analogue phloridzin inhibited the uptake of myo-inositol. Phloretin acted as an uncompetitive or noncompetitive inhibitor, whereas phloridzin had a K, of about 60 pM. similar to the K, for mvo-inositol. Glucose and galactose were very weak competitive inhibitors, with a K, of 30 and 65 mM, respectively. The sodium dependence of myo-inositol uptake was somewhat complex. Using 30-min incubations to assess the initial rate of myo-inositol transport, we found a weak dependency on sodium concentration only at 1 1 pM myo-inositol. At mjo-inositol concentrations above 200 pM, the initial rate of uptake was actually higher at 23 mM sodium. When the time course of myo-inositol uptake was examined in media with varying sodium concentrations, we found that uptake ceased after about 1 h at the lowest sodium concentration of 23 mM. A time-dependent decline in the transport rate for myo-inositol under low sodium conditions was also observed in rat Schwann cells (27) .
On repeated subculturing in media containing more than 200 among cell lines, but each line maintained a constant mjluinositol level with passage. The different cell lines showed little variation in the rate of myo-inositol uptake, and thus no correlation, positive or negative, existed between transport capacity and cellular levels of myo-inositol. This finding is somewhat surprising and suggests that other factors. perhaps of a genetic nature, help to regulate the cell content of m,tvo-inositol. Although the synthetic rates still must be measured in different fibroblast lines, we believe that these variations are not due to rnjv-inositol synthesis. Even cells whose survival depends on the availability of myo-inositol as an intracellular osmolyte fail to use dc novo synthesis in the regulation of levels (29) . The stability of mjtoinositol levels within our cell lines is further supported by the fact that little intraexperimental or interexperimental variation occurred in measured uptake, whether time or mjv-inositol concentration dependent, for a particular cell line despite abrupt declines in ambient myo-inositol concentrations as the cells were routinely switched to serum-free media for study. Although the rates of uptake are not of the same magnitude as other solute transport systems, the uptake data suggest that at a normal serum myo-inositol concentration of 50 pM. fibroblasts would exchange about one third of their myo-inositol with the medium in 24 h. The incorporation of mjvo-[2-'Hlinositol into phospholipid paralleled its uptake into the cell. Essentially no label was found in membranes for the first 30 min of incubation. and incorporation continued in a linear fashion after the uptake had leveled off.
Even after 24 h, the label in lipid was only about 10% that in the myo-inositol pool. The response of human skin fibroblasts to elevated levels of glucose is of interest because they may be involved in alterations of the skin seen in diabetic patients in the enigmatic diabetic connective tissue syndromes (30, 31) . Apropos of the question of whether high blood glucose levels induce pathologic effects on the fibroblast, Turner and Bierman (32) had previously shown that cultured fibroblasts exposed to 10-20 mM glucose manifested an up-regulated cell proliferative response to FBS. Importantly, however, these mesodermal elements differ from many of the other cells or tissues conspicuously involved in diabetic complications or previously shown to be affected by high sugar levels in vitro in that they possess a system for glucose transport that is both of low capacity and, albeit weakly, insulin dependent (33, 34) . Thus. we would not expect elevated medium glucose levels to result in a significant elevation of intracellular-free glucose and sorbitol. Further, glucose has not been found to be a strong competitive inhibitor of mjv-inositol transport in human skin fibroblasts (17) . In contrast, our experiments, as well as other studies (18) , show that human skin fibroblasts readily take up galactose and convert it to galactitol.
We examined the effects of a 24-or 48-h exposure of human skin fibroblasts to elevated sugar concentrations. Raising the medium glucose concentration to 20 mM for 24 h had little effect on intracellular carbohydrate levels. The increase in cellular glucose and polyol did not achieve statistical significance. In contrast, fibroblasts incubated in normal MEM supplemented with only 5 mM galactose accumulated free galactose and polyol to a level 10 or more times that in control cells. Neither elevated glucose nor galactose in the presence of more than 200 pM myfr inositol had an effect on the cellular mjlo-inositol levels during this time period.
In other experiments, the uptake and incorporation of mvoinositol for 2 to 4 h was examined in the presence of 20 mM glucose or 15 mM galactose. Neither sugar inhibited the uptake of myo-inositol when it was presented only during the 2-to 4-h incubation period. This finding is not surprising given the weak competitive effect of glucose or galactose observed in 30-min transport experiments. However, cells incubated with 20 mM glucose for 24 h showed a small decrease in mj~trinositol uptake. After 48 h, both sugars appeared to reduce m~~o-inositol uptake 146 BERRY and metabolism. It might be expected that this effect was not related to accumulation of polyol because incubation with galactose produced much greater polyol accumulation but no greater inhibition of mjlo-inositol transport. Furthermore, because the effect on uptake was "delayed" and yet neither sugar was a significant competitive inhibitor of transport, this effect may not be related to com~etitive inhibition. In addition. this unex~lained diminution in mio-inositol uptake may not even be dependent on intracellular glucose or galactose levels. Time may be a key factor in the full expression of sugar toxicity. For example, Okuda ef al. (35) showed that chronic exposure to extremely high concentrations of glucose, i.e. subculturing fibroblasts in media with 28 and 55 mM glucose, albeit in the presence of myoinositol in excess of 150 gM, resulted in reduced uptake of 50 pM myo-inositol that was partially polyol pathway dependent.
Our data show that prolonged exposure of human skin fibroblasts to elevated glucose or galactose concentrations resulted in a modest reduction in myc-inositol transport when they were subsequently studied at a concentration of myo-inositol typical of the adult organism. Furthermore. this reduction was detected even though the concentration of myo-inositol in the FBSsupplemented media had been in excess of 200 gM. The physiologic significance of this effect remains to be determined. It may be a singular manifestation of a more generalized defect in membrane function. If found to be significant despite no detectable reduction in cell myo-inositol levels, it would support the concept that persistent elevation of extracellular hexose interferes with the maintenance of a small pool of myc~inositol important in cell metabolism ( 5 . 36). It is unclear why fibroblast mytr inositol content varies by as much as 5-fold in the different cell lines and provokes the consideration of how relevant the measurement of total cell myo-inositol is to fibroblast metabolism. Molitoris et al. (37) suggested that mvc~inositol is largely sequestered or bound in skeletal muscle tissue. Several investigators have also alluded to the presence of more than one pool of mj3tr inositol in certain cells or tissues (23. 38, 39) . Despite millimolar levels of myo-inositol in cells, only micromolar concentrations may be sufficient for optimal membrane phosphatidylinositol biosynthesis (23, 40, 41). We recently provided kinetic evidence to support a hypothesis that the cytosolic concentration of unbound metabolically active mjv-inositol in the hepatocyte is closer to the extracellular concentration than the total measurable level (42). A similar physiologic condition might pertain to the fibroblast, with variations in total levels in different cell lines being related to genetic factors that affect mvo-inositol sequestration within organelles or binding to macromolecules. It is clear that any new insight into the effects of sugar toxicity on mjloinositol metabolism is dependent on a better understanding of myo-inositol metabolism per se. Human skin fibroblasts in culture may provide a unique system for dissociating the effects of hexose and polyol toxicity on cell metabolism.
